@article{article, title  = {{P3-093: Correlative analyses of plasma cytokine / angiogenic factor (C/AF) profile, gender and outcome in a randomized, three-arm, phase II trial of 1st-line vandetanib (VAN) and / or carboplatin plus paclitaxel (CP) for advanced non small cell lung cancer (NSCLC).}},

 publisher = {{Elsevier}},

 url = {{}},

 year = {{2007}},

 month = {{8}},

 author = {{Heymach JV and Hanrahan EO and Lin HY and Du DZ and Yan S and Kim ES and Lee JJ and Ryan AJ and Tran HT and Johnson BE}},

 doi = {{10.1097/01.jto.0000284069.35181.74}},

 volume = {{2}},

 journal = {{Journal of Thoracic Oncology}},

 issue = {{8}},

 pages = {{s718}},

 note = {{Accessed on 2026/03/02}}}